amyloidosis

Also found in: Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.

Related to amyloidosis: familial amyloidosis

am·y·loid·o·sis

(ăm′ə-loi-dō′sĭs)

Any of a group of diseases or conditions characterized by the formation and deposition of amyloid in various organs and tissues of the body.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

amyloidosis

(ˌæmɪlɔɪˈdəʊsɪs)

(Pathology) pathol the deposition of amyloid in various tissues of the body, as occurs in certain chronic infections

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Noun

amyloidosis - a disorder characterized by deposit of amyloid in organs or tissues; often secondary to chronic rheumatoid arthritis or tuberculosis or multiple myeloma

illness, sickness, unwellness, malady - impairment of normal physiological function affecting part or all of an organism

Translations

am·y·loi·do·sis

n. amiloidosis, acumulación de amiloide en los tejidos.

English-Spanish Medical Dictionary © Farlex 2012

amyloidosis

n amiloidosis f

Mentioned in ?

References in periodicals archive ?

Alnylam Pharmaceuticals shared new findings at the Second European Meeting of ATTR Amyloidosis, or EU-ATTR, for Doctors and Patients, being held September 2-3, in Berlin, Germany.

Alnylam presented results from Apollo Phase 3 study of Onpattro

(NASDAQ: IONS), today announced that data from the NEURO-TTR open-label study along with data from the AKCEA-TTR-LRx program and additional clinical presentations on the efficacy and safety profile of TEGSEDI will be presented at the 2nd European ATTR Amyloidosis Alliance Meeting in Berlin, Germany, September 2-3, 2019.

Akcea and Ionis to Present New Data for TEGSEDI and AKCEA-TTR-LRx at Two Upcoming Medical Meetings

Right now, almost 47 million cognitively normal people in the United States may have brain amyloidosis, the physical finding used to define preclinical Alzheimer's disease (AD).

Up to 47 million Americans may have brain amyloidosis

Memorial donations may be made in Terry's name to the Amyloidosis Foundation at www.amyloidosis.org.

DIXON

APML Overseas President Afzaal Siddiqui told DawnNewsTV that Musharraf had suffered a reaction from amyloidosis, a rare condition for which the former president has been receiving medical care.

Musharraf shifted to Dubai hospital after 'reaction' from rare disease

Summary: Musharraf suffered a reaction from amyloidosis, a rare condition

Former Pakistan president Pervez Musharraf admitted to Dubai hospital after reaction from rare disease: Party

Caelum Biosciences has signed a strategic agreement with Alexion Pharmaceuticals to advance the development of CAEL-101 for light chain (AL) amyloidosis.

Caelum Biosciences, Alexion

Caelum Biosciences, a subsidiary of Fortress Biotech, has signed a strategic agreement with United States-based Alexion Pharmaceuticals to advance the development of CAEL-101 for light chain (AL) amyloidosis, a rare systemic disorder caused by an abnormality of plasma cells in the bone marrow, it was reported on Friday.

Caelum Biosciences signs strategic agreement with Alexion Pharmaceuticals

and Caelum Biosciences have collaborated to develop CAEL-101 for light chain (AL) amyloidosis. CAEL-101 is a first-in-class amyloid fibril targeted therapy designed to improve organ function by reducing or eliminating amyloid deposits in patients with AL amyloidosis.

ALEXION & CAELUM DEBUT CAEL-101 FOR AL AMYLOIDOSIS

In amyloidosis, abnormal proteins are deposited in tissues anywhere in the body.

Using Carpal Tunnel Syndrome to Diagnose Cardiac Amyloidosis Early

Amyloidosis is a disease characterized by extracellular accumulation of amyloid protein in different organs and tissues.